Skip to main content
. 2006 Jul 14;103(31):11742–11747. doi: 10.1073/pnas.0604244103

Table 2.

Engraftment frequency of mice to which hESC-derived CD34+ or CD133+ CD34 cells had been transferred

Cells Day 7 Day 10 Day 11 Day 14
Experiment 1
    CD133+ NT 3/5 NT 0/3
    CD34+ NT 2/5 NT 1/3
Experiment 2
    CD133+ 1/3 NT 2/7 NT
    CD34+ 1/4 NT 1/2 NT
Experiment 3
    CD133+ NT 3/4 NT NT
    CD34+ NT 3/5 NT NT

Two experiments with SCID-hu mice (experiments 1 and 2) and one experiment with RAG-hu mice (experiment 3) are shown. Those mice found positive for engraftment were determined to have CD45+, EGFP+ cells at the indicated time points. NT, not tested.

HHS Vulnerability Disclosure